BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 14769212)

  • 41. Trilobatin as an HIV-1 entry inhibitor targeting the HIV-1 Gp41 envelope.
    Yin S; Zhang X; Lai F; Liang T; Wen J; Lin W; Qiu J; Liu S; Li L
    FEBS Lett; 2018 Jul; 592(13):2361-2377. PubMed ID: 29802645
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel peptide shows excellent anti-HIV-1 potency as a gp41 fusion inhibitor.
    Liu W; An X; Wang J; Zhang X; Tan J; Zhou Z; Zeng Y
    Bioorg Med Chem Lett; 2018 Mar; 28(5):910-914. PubMed ID: 29433929
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design, synthesis, and biological evaluation of N-carboxyphenylpyrrole derivatives as potent HIV fusion inhibitors targeting gp41.
    Liu K; Lu H; Hou L; Qi Z; Teixeira C; Barbault F; Fan BT; Liu S; Jiang S; Xie L
    J Med Chem; 2008 Dec; 51(24):7843-54. PubMed ID: 19053778
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [How antiretroviral medicines work].
    Iofolla M
    Sidahora; 2003; (1):18-21. PubMed ID: 12733498
    [No Abstract]   [Full Text] [Related]  

  • 45. Computer-aided design, synthesis, and biological activity evaluation of potent fusion inhibitors targeting HIV-1 gp41.
    Tan JJ; Zhang B; Cong XJ; Yang LF; Liu B; Kong R; Kui ZY; Wang CX; Hu LM
    Med Chem; 2011 Jul; 7(4):309-16. PubMed ID: 21568877
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 3-Hydroxyphthalic anhydride-modified human serum albumin as a microbicide candidate inhibits HIV infection by blocking viral entry.
    Li L; Qiu J; Lu L; An S; Qiao P; Jiang S; Liu S
    J Antimicrob Chemother; 2013 Mar; 68(3):573-6. PubMed ID: 23221626
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Design, synthesis, and biological activity of novel 5-((arylfuran/1H-pyrrol-2-yl)methylene)-2-thioxo-3-(3-(trifluoromethyl)phenyl)thiazolidin-4-ones as HIV-1 fusion inhibitors targeting gp41.
    Jiang S; Tala SR; Lu H; Abo-Dya NE; Avan I; Gyanda K; Lu L; Katritzky AR; Debnath AK
    J Med Chem; 2011 Jan; 54(2):572-9. PubMed ID: 21190369
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Virus-inhibitory peptide: a natural HIV entry inhibitor in search for a formal target in the viral genome.
    Quiñones-Mateu ME; Schols D
    AIDS; 2011 Aug; 25(13):1663-4. PubMed ID: 21811104
    [No Abstract]   [Full Text] [Related]  

  • 49. Anti-HIV-1 activity of anionic polymers: a comparative study of candidate microbicides.
    Neurath AR; Strick N; Li YY
    BMC Infect Dis; 2002 Nov; 2():27. PubMed ID: 12445331
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting a Conserved Lysine in the Hydrophobic Pocket of HIV-1 gp41 Improves Small Molecule Antiviral Activity.
    He L; Zhou G; Sofiyev V; Garcia E; Nguyen N; Li KH; Gochin M
    Viruses; 2022 Dec; 14(12):. PubMed ID: 36560708
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Discovery of natural mouse serum derived HIV-1 entry inhibitor(s).
    Wei M; Chen Y; Xi J; Ru S; Ji M; Zhang D; Fang Q; Tang B
    Acta Virol; 2016; 60(4):404-409. PubMed ID: 27928921
    [TBL] [Abstract][Full Text] [Related]  

  • 52. N-Substituted Pyrrole Derivative 12m Inhibits HIV-1 Entry by Targeting Gp41 of HIV-1 Envelope Glycoprotein.
    Qiu J; Liang T; Wu J; Yu F; He X; Tian Y; Xie L; Jiang S; Liu S; Li L
    Front Pharmacol; 2019; 10():859. PubMed ID: 31427969
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Automatic quantitation of HIV-1 mediated cell-to-cell fusion with a digital image analysis system (DIAS): application for rapid screening of HIV-1 fusion inhibitors.
    Lu H; Zhao Q; Xu Z; Jiang S
    J Virol Methods; 2003 Feb; 107(2):155-61. PubMed ID: 12505629
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gene genie. Can gene therapy deliver a better fusion blocker?
    Huff B
    GMHC Treat Issues; 2003 Dec; 17(12):7. PubMed ID: 15011644
    [No Abstract]   [Full Text] [Related]  

  • 55. [Polyphenols as anti-HIV agents].
    Sakagami H; Takeda M
    Nihon Rinsho; 1993 Sep; 51 Suppl():127-31. PubMed ID: 8271375
    [No Abstract]   [Full Text] [Related]  

  • 56. Tannin constituents of Terminalia glaucescens.
    Koudou J; Roblot G; Wylde R
    Planta Med; 1995 Oct; 61(5):490-1. PubMed ID: 7480219
    [No Abstract]   [Full Text] [Related]  

  • 57. [Effect of tannin, saponin and guanidine on the replication of Echovirus 9 and its mutants].
    Jabłoński L; Polz M
    Med Dosw Mikrobiol; 1980; 32(2):121-5. PubMed ID: 7464352
    [No Abstract]   [Full Text] [Related]  

  • 58. Induction of apoptosis and anti-HIV activity by tannin- and lignin-related substances.
    Sakagami H; Satoh K; Ida Y; Koyama N; Premanathan M; Arakaki R; Nakashima H; Hatano T; Okuda T; Yoshida T
    Basic Life Sci; 1999; 66():595-611. PubMed ID: 10800465
    [No Abstract]   [Full Text] [Related]  

  • 59. [Antibiotic activity of a tannin-tormentol complex extracted from the salad burnet (Poterium sanguisorba L.)].
    JANOT MM; POURRAT H; FEBVRE P
    Ann Pharm Fr; 1955 Mar; 13(3):167-8. PubMed ID: 14388438
    [No Abstract]   [Full Text] [Related]  

  • 60. Correction: Heterologous gene expression system for the production of hydrolyzable tannin intermediates in herbaceous model plants.
    Oda-Yamamizo C; Mitsuda N; Milkowski C; Ito H; Ezura K; Tahara K
    J Plant Res; 2023 Nov; 136(6):947. PubMed ID: 37589837
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.